Skip to main content

Reporter April 2 2021

Genetic differences in Wilms tumor

Apr. 6, 2021—Unique somatic gene mutations may contribute to racial disparities in the incidence of Wilms tumor — the most common childhood kidney cancer.

Read more


Codeine metabolizer status in clinical practice

Apr. 5, 2021—Vanderbilt researchers have developed a response score using genetic and clinical information to aid prescribing of the widely used pain medication codeine.

Read more


Study links ADHD pharmacotherapy and retention rates for substance use disorder treatment

Apr. 2, 2021—Kristopher Kast, MD, assistant professor in the Department of Psychiatry and Behavioral Sciences and clinical director of Vanderbilt’s Addiction Consult Service, has discovered a strong association between attention-deficit/hyperactivity disorder (ADHD) pharmacotherapy and retention rates for substance use disorder (SUD) treatment.

Read more


Investigational vaccine to be tested against COVID-19 variant

Apr. 2, 2021—Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.

Read more


Dixie Place renamed in honor of Vanderbilt surgical pioneer Vivien Thomas

Apr. 1, 2021—Through a Vanderbilt University School of Medicine student-led effort, Dixie Place, the city street that runs between the Medical Center’s Central Garage and the Oxford House building on 21st Avenue South, is being renamed Vivien Thomas Way.

Read more


COVID-19 met with intensive teamwork

Apr. 1, 2021—Team members serving COVID-19 inpatients were more densely connected, interacting far more than their medical ICU counterparts.

Read more


Novel way to neutralize Rift Valley Fever Virus

Apr. 1, 2021—The discovery of monoclonal antibodies that neutralize Rift Valley Fever Virus — an emerging infection with pandemic potential — lays the foundation for future therapeutic antibody development.

Read more


COVID recovery included long stay on ECMO, double-lung transplant

Apr. 1, 2021—Zach Lloyd was only 37 years old with no pre-existing health conditions, but COVID-19 was bringing him within an inch of his life.

Read more


Breast cancer cells ‘steal’ nutrients from immune cells: study

Apr. 1, 2021—Triple-negative breast cancer cells engage in a “glutamine steal” — outcompeting T cells for the nutrient glutamine and impairing their ability to kill tumor cells, Vanderbilt researchers have discovered.

Read more


Study outlines VUMC’s strategy for a learning health care system

Apr. 1, 2021—New investments in clinical programs at Vanderbilt University Medical Center are increasingly contingent upon studies to validate claims of benefit and the potential for scalability and spread.

Read more


Study shows new COVID target could improve vaccines

Apr. 1, 2021—Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus.

Read more


Analysis seeks to better manage infection in dialysis patients

Apr. 1, 2021—Analysis seeks to better manage infection in dialysis patients

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more